But how do herpes viruses manage to survive and multiply in the human body? How can new, improved drugs be developed that complement already existing medications? The RESIST team is seeking answers to these questions. Its researchers want to make herpes viruses vulnerable for attack, especially during their dormant stage. The investigated pathogens in Project Area D include the Cytomegalovirus, the Varicella Zoster Virus, the Kaposi Sarcoma Virus and the Herpes Simplex Virus. Moreover, on the site of the host RESIST investigators analye innate immunse senosrs for development of novel therapeutic approaches against infectious and inflammatory diseases.